主记录
GSK-626616
- CAS
- 1025821-33-3
- PubChem CID
- 135416229
- SMILES
- C1=CC(=C(C(=C1)Cl)N=C2NC(=O)/C(=C/C3=CC4=NC=CN=C4C=C3)/S2)Cl
- 分子式
- C18H10Cl2N4OS
- 分子量
- 401.278
- 精确分子量
- 399.9952
- InChI
- InChI=1S/C18H10Cl2N4OS/c19-11-2-1-3-12(20)16(11)23-18-24-17(25)15(26-18)9-10-4-5-13-14(8-10)22-7-6-21-13/h1-9H,(H,23,24,25)/b15-9-
- InChIKey
- RJPNRXFBYZVRIB-DHDCSXOGSA-N
- LogP
- 4.8282
- TPSA
- 67.24
名称与别名
- GSK-626616
- 1025821-33-3
- OKY0RM282V
- RefChem:782735
- UNII-OKY0RM282V
- C18H10Cl2N4OS
- CHEMBL5081787
- GSK 626616
- orb1308256
- SCHEMBL2993698
- SCHEMBL13041788
- SCHEMBL13041807
- SCHEMBL29716638
- (5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone
- GSK626616
- RJPNRXFBYZVRIB-DHDCSXOGSA-N
- GLXC-15470
- EX-A3477
- BDBM50613085
- MFCD31689261
- GSK 626616 - Bio-X trade mark
- AKOS040741813
- AC-36386
- AS-76659
- BG166664
- BG300011
- DA-53718
- HY-105309
- CS-0025705
- J3.165.566H